Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
07/2012
07/17/2012US8222384 Modified and stabilized GDF propeptides and uses thereof
07/17/2012US8222258 Stable pharmaceutical composition of freeze-dried tetrodoxin powder
07/17/2012US8222212 Prolactin induced increase in neural stem cell numbers
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/12/2012WO2012094636A2 Chemosensory receptor ligand-based therapies
07/12/2012WO2011152618A4 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
07/12/2012US20120178809 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
07/12/2012US20120178776 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators
07/12/2012US20120178718 Novel imidazolidine compounds as androgen receptor modulators
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178672 Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177610 Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
07/12/2012US20120177605 Delivery of Polynucleotides Across the Blood-Brain-Barrier Using Recombinant AAV9
07/11/2012EP2473607A2 Exon skipping therapy for functional amelioration of semi functional dystrophin in becker and duchenne muscular dystrophy
07/11/2012EP1487778B1 Substituted 4-aminocyclohexanols
07/11/2012CN1839847B Tizanidine hydrochloride oral disintegrating tablet and preparation method thereof
07/11/2012CN102573794A Cysteine for physiological injection
07/11/2012CN102558276A Non-sizing pipecuronium and preparation method and purpose thereof
07/11/2012CN102558093A Agents for preventing and treating disorders involving modulation of the ryr receptors
07/11/2012CN102552867A Medicinal extract for curing pains on neck, shoulder, waist and leg and preparing method thereof
07/11/2012CN102552381A Medicine for treating myasthenia gravis
07/11/2012CN102552135A Method for preparing vitamin K1 emulsion, and vitamin K1 emulsion
07/11/2012CN102552107A Two-phase release preparation containing zolpidem or salt of zolpidem and preparation method thereof
07/11/2012CN101139345B Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
07/10/2012US8217146 Neurotrophic factors and methods of use thereof
07/10/2012US8217138 Anti-inflammatory compounds and uses thereof
07/10/2012US8216615 Pawpaw and peach derived composition
07/10/2012US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1
07/10/2012CA2519898C Oral administration of cyclic protein tyrosine kinase inhibitors
07/10/2012CA2510893C Binding agents which inhibit myostatin
07/10/2012CA2400916C Aminoadamantane derivatives as therapeutic agents
07/05/2012WO2012092035A1 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
07/05/2012WO2012091571A2 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091549A1 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091542A1 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012088597A1 Nitric oxide amino acid esters for enhancement of physical or muscular performance and the treatment of muscular or neuromuscular diseases
07/05/2012WO2012030919A3 Composition and method for muscle repair and regeneration
07/05/2012US20120172450 Use of jasmonate for improving skeletal muscle function
07/05/2012US20120172415 Exon Skipping Therapy for Functional Amelioration of Semifunctional Dystrophin in Becker and Duchenne Muscular Dystrophy
07/05/2012US20120172363 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172353 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171222 Methods and compositions involving nucleotide repeat disorders
07/05/2012CA2823306A1 Combination of components for the prevention and treatment of frailty
07/05/2012CA2821312A1 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
07/04/2012EP2471916A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis
07/04/2012EP2470214A1 Method of treating frailty
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012CN102548945A Apogossypolone derivatives as anticancer agents
07/04/2012CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
07/04/2012CN102532133A Azaindoles useful as inhibitors of janus kinases
07/04/2012CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds
07/04/2012CN102526736A Treatment of inflammatory diseases
07/04/2012CN102526726A Myoglobin immunoadsorbent and immunoadsorption device
07/04/2012CN102526502A Chinese medicine preparation for treating myasthenia gravis
07/04/2012CN102526491A Paste for treating bone diseases and preparation method thereof
07/04/2012CN102526389A Traditional Chinese medicine for treating myasthenia gravis and amyotrophy
07/04/2012CN102525917A Nimodipine micelle injection and preparation method thereof
07/04/2012CN101745088B Damp pain-relieving rubber paste and making method thereof
07/04/2012CN101597272B Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof
07/03/2012US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/03/2012US8211671 Activatable recombinant neurotoxins
07/03/2012CA2535953C Treating bone-related disorders with selective androgen receptor modulators
07/03/2012CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
07/03/2012CA2409647C Methods of treating androgen deficiency in men using selective antiestrogens
06/2012
06/28/2012WO2012085586A1 Mexiletine prodrugs
06/28/2012US20120165782 pharmaceutical composition of an iontophoresis
06/28/2012US20120165394 Spinal muscular atrophy (sma) treatment via targeting of smn2 splice site inhibitory sequences
06/28/2012US20120165363 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165243 Use of dietary fibres against muscle wasting
06/28/2012US20120164245 Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
06/28/2012US20120164243 Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164151 Methods for Treatment of Muscular Dystrophy
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012US20120164078 Methods of using sustained release aminopyridine compositions
06/27/2012EP2467159A1 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
06/27/2012CN102516352A Smilagenin in crystalline and amorphous forms
06/27/2012CN102029015B Blood circulation-promoting and cold-protecting health care bag
06/27/2012CN101601789B Medicament for treating lipid storage myopathy and preparation method thereof
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/21/2012WO2012081570A1 Lactam compound or a salt thereof, and ppar activator
06/21/2012WO2012058220A3 Anti-sod1 antibodies and uses thereof
06/21/2012WO2012037083A3 Compositions and method for promoting musculoskeletal repair
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157398 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120156309 Using Aqueous Oxygenation to Improve Animal Health & Wellness
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 233